Moderna Inc on Thursday (Nov 4) slashed the 2021 sales forecast for its Covid-19 vaccine by as much as $5 billion (S$6.7 billion), grappling to fill vials and distribute them to meet unprecedented world demand, sending its shares tumbling 16 per cent. Moderna executives said production challenges now lie with bottling up doses, also known as...
The Pfizer/BioNTech vaccine is authorised for children as young as 12, and the companies are seeking authorisation for use in those as young as five years of age.Reuters WASHINGTON - The Pfizer/BioNTech Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the US Centres...
An experimental Covid-19 treatment pill called molnupiravir being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP.Reuters file As Merck & Co and Pfizer Inc prepare to report clinical trial results for experimental Covid-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their...
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken on Oct 31, 2020.Reuters file Moderna Inc has withheld supply of about 1.63 million doses in Japan after it was notified of contamination of its Covid-19 vaccine vials...
The Covid-19 vaccine developed by Chinese company Sinovac is safe and effective for children as young as three, early stage human trials have found, as China seeks to expand immunisation coverage. The vaccine, which gained World Health Organisation emergency use approval for adults earlier this month, has already been approved for emergency use for children above...
Vials with a sticker reading, "Covid-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken Oct 31, 2020.Reuters Malaysia will procure an additional 12.8 million doses of coronavirus vaccine jointly developed by Pfizer and BioNTech in a bid to ramp up its...
A new paper suggests that vaccine makers using adenovirus vectors could modify the sequence of the spike protein.Reuters German researchers on Wednesday (May 26) said that based on laboratory research, they believed they have found the cause of the rare but serious blood-clotting events among some people who received Covid-19 vaccines made by AstraZeneca and Johnson...
A nurse prepares a dose of China's Sinopharm coronavirus disease (Covid-19) vaccine at a health center in Caracas, Venezuela, on March 7, 2021.Reuters Two Covid-19 vaccines from China's Sinopharm showed more than 70 per cent efficacy against symptomatic cases, but it remains unclear how much protection they provide against severe or asymptomatic cases, according to the...
The Pfizer candidate is a protease inhibitor that prevents the virus from replicating in cells.Reuters Pfizer has started an early-stage US trial of an oral Covid-19 antiviral therapy that could be prescribed to patients at the first sign of infection, the company said on Tuesday (March 23). The drugmaker, which developed the first authorised Covid-19 vaccine in...
The preliminary data was from Phase I and II clinical trials involving over 500 people.Reuters Sinovac Biotech's Covid-19 vaccine appears to be safe and able to trigger immune responses among children and adolescents, according to preliminary results from early and mid-stage trials, the company said late on Monday (March 22). The preliminary data was from Phase I...
